A Study of Olanzapine in Participants With Bipolar Disorder.
ConditionBipolar Disorder
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorBoryung Pharmaceutical Co., Ltd
About this trial
This study aimed to identify treatment patterns in patients with bipolar disorder receiving olanzapine according to demographic and clinical characteristics and to evaluate the effectiveness of education on weight gain, a side effect of olanzapine, in preventing weight gain.
Eligibility criteria
Qualifiers
Patients who have signed the informed consent after receiving information about the purpose and method of this study.
Patients diagnosed with bipolar disorder and scheduled to receive olanzapine.
Patients who understand the contents of the survey and can answer the questions directly.
Disqualifiers
Female patients who are pregnant, have childbearing potential, or are breastfeeding.
Has received an investigational product within 12 weeks from the study enrollment or has plans to participate in another clinical trial during the participation of this study.
Other subjects who are considered inappropriate to participate in this study by the judgment of the investigator.
Trial design
Treatments tested in this trial
- Olanzapine
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov